Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 8/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13254845 | 0.93 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL385345 | 0.93 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL4445192 | 0.93 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL10757334 | 0.91 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL10591026 | 0.89 | DPP7 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL2824467 | 0.89 | NPC1 (0.56) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL10752905 | 0.89 | DPP7 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL3169796 | 0.84 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL1419834 | 0.84 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL6214888 | 0.84 | DPP7 (0.39) | NPC1RAB9ASMN1; SMN2DPP7POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2751090-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | Gilead Sciences, Inc. (US) | 2014-07-09 | — | — | EP | disclosed |
| US-8673966-B2 | ALDH-2 inhibitors in the treatment of addiction | GILEAD SCIENCES, INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-20130231325-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | GILEAD SCIENCES. INC. (US) | 2013-09-05 | — | — | US | disclosed |
| WO-2013033377-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | GILEAD SCIENCES, INC. (US) | 2013-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231325-A1 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | ALDH1A1, ADH1A, ALDH1B1 | NPC1 2357/4885RAB9A 2880/4885SMN1; SMN2 1988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.